Omada Health vs Amgen
Side-by-side comparison of AI visibility scores, market position, and capabilities
Omada Health is a virtual-first chronic care platform for diabetes, hypertension, and musculoskeletal conditions serving 2,000+ employer and health plan customers, with $170M 2024 revenue and a June 2025 Nasdaq IPO (OMDA).
About
Omada Health is a San Francisco-based digital health company founded in 2012 that offers virtual-first care programs for chronic conditions including prediabetes, Type 1 and Type 2 diabetes, hypertension, and musculoskeletal disorders. The platform combines human health coaches, licensed clinical practitioners, and connected devices—including cellular-enabled scales and continuous glucose monitors—with behavior science and clinical protocols to deliver personalized, data-driven care at scale. Omada describes its approach as "Compassionate Intelligence," integrating human relationships with AI-driven personalization.
Amgen (AMGN) reported $33.4B revenue in FY2024, up 19% YoY (post-Horizon acquisition). Top-5 global biotech. 10+ blockbuster drugs. ~24,000 employees. HQ: Thousand Oaks, CA. Market cap ~$130B.
About
Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologics and brought landmark medicines including Epogen, Neupogen, and Enbrel to market. The company reported revenues of $33.4B in FY2024, up 19% year-over-year, boosted by the transformational $28B acquisition of Horizon Therapeutics in October 2023.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.